First patient treated in Phase 2 A-TANGO trial for acute-on-chronic liver failure

Phase 2Positive

AI Analysis

Summary

TRAX announced the first patient treated in the Phase 2 A-TANGO trial evaluating an innovative combination treatment for acute-on-chronic liver failure.

Clinical Trial Data

Phase

Phase 2

Outcome Details

First patient treated in Phase 2 A-TANGO trial

Importance:5/10

Sentiment:

0.50

Phase 2clinical trialacute-on-chronic liver failureA-TANGO

Related Companies

$TRAX

Read the original article

Published by GlobeNewswire Clinical Studies on July 13, 2026 12:47 PM

Read Original